JCRB1838 HeLa-TMPRSS2
Cell information
Cell type：genetically-modified cells (View Pricing Information)
| JCRB No. | JCRB1838 | Cell Name | HeLa-TMPRSS2 |
|---|---|---|---|
| Profile | HeLa cells expressing the transmembrane serine protease TMPRSS2. Recommended use: Isolation of human coronavirus 229E (HCoV-229E) | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | F | Age | 31-year-old |
| Identity | not done | Tissue for Primary Cancer | uterine cervix |
| Case history | carcinoma of cervix | Metastasis | |
| Tissue Metastasized | Genetics | ||
| Life Span | infinite | Crisis PDL | |
| Morphology | epithelial-like | Character | |
| Classify | tumor | Established by | Shirato, Kazuya |
| Registered by | Kazuya Shirato | Regulation for Distribution | |
| Comment | Year | ||
| Medium | DMED+5%FCS+G418(1mg/ml)+PS(FUJIFILM WAKO Chemicals No.168-23191,etc.) | Methods for Passages | Trypsin-EDTA(Kojin Bio Co.,Ltd :No.16208004, etc.) |
| Cell Number on Passage | Race | Black | |
| CO2 Conc. | 5% | Tissue Sampling | cervix |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | + | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:24027332 | Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. Shirato K,Kawase M,Matsuyama S J Virol. 2013 Dec;87(23):12552-61 |
| Images |
|---|
     |
| Movies |
|---|
|
LOT Information
| Cell No. | JCRB1838 | Cell Name | HeLa-TMPRSS2 |
|---|---|---|---|
| LOT No. | 12252020 | Lot Specification | distribution |
| Medium | DMEM(GIBCO：Cat No.;11885-084) with G-418(1mg/ml) and 5% heat inactivated fetal bovine serum(SIGMA,Cat#172012,Lot#12J396) | Temperature | 37 C |
| Cell Density at Seeding | 1.00-2.00x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.1%trypsin(GIBCO) and 0.02% EDTA. |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.87x10^6 |
| Viability at cell freezing (%) | 96.00 | Antibiotics Used | G-418 |
| Passage Number | p9* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:11,12 D13S317:13.3,14.3 D7S820:8,12,13 D16S539:9,10 VWA:16,18,19 TH01:7 AM:X TPOX:8,12 CSF1PO:10 |
| Adhesion | Yes | Exoteric Gene | NT |
| Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 97.4 | Additional information |
| Images |
|---|
|
|